Контрацепция после родов: современные достижения и перспективы
Контрацепция после родов: современные достижения и перспективы
Прилепская В.Н., Назаренко Е.Г. Контрацепция после родов: современные достижения и перспективы. Гинекология. 2024;26(1):5–10. DOI: 10.26442/20795696.2024.1.202605
Prilepskaya VN, Nazarenko EG. Contraception after childbirth: current achievements and prospects: A review. Gynecology. 2024;26(1):5–10. DOI: 10.26442/20795696.2024.1.202605
Контрацепция после родов: современные достижения и перспективы
Прилепская В.Н., Назаренко Е.Г. Контрацепция после родов: современные достижения и перспективы. Гинекология. 2024;26(1):5–10. DOI: 10.26442/20795696.2024.1.202605
Prilepskaya VN, Nazarenko EG. Contraception after childbirth: current achievements and prospects: A review. Gynecology. 2024;26(1):5–10. DOI: 10.26442/20795696.2024.1.202605
В статье представлены современные методы контрацепции после родов, в том числе с характеристиками особенностей их влияния на состояние матери и ребенка, основные преимущества и недостатки. С этих позиций особое внимание уделено барьерным методам контрацепции – спермицидам согласно «Критериям приемлемости» Всемирной организации здравоохранения (2015 г.) и «Национальным критериям приемлемости» (2023 г.), их особенностям и перспективам применения.
Ключевые слова: послеродовая контрацепция, кормящие женщины, барьерные методы контрацепции, спермициды
________________________________________________
The article presents modern methods of contraception after childbirth, including their impact on the mother and child, the main advantages and disadvantages. Special attention is paid to barrier methods of contraception, spermicides, and their advantages according to the "Acceptance Criteria" of the World Health Organization (2015) and the "National Acceptance Criteria" (2023), their features and prospects for use.
Keywords: postpartum contraception, lactating women, barrier methods of contraception, spermicides
1. Михайлова О.И., Вересова А.А. Особенности послеродовой контрацепции в современных условиях. Эффективная фармакотерапия. Акушерство и Гинекология.
2013;2:26-30 [Mikhailova OI, Veresova AA. Osobennosti poslerodovoi kontratseptsii v sovremennykh usloviiakh. Effektivnaia farmakoterapiia. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2013;2:26-30 (in Russian)].
2. Бахарева И.В. Контрацепция после родов: оптимальный выбор. Российский медицинский журнал. Мать и дитя. 2020;3(1):31-8 [Bakhareva IV. Postpartum contraception: optimal choice. Russian Journal of Woman and Child Health. 2020;3(1):31-8 (in Russian)]. DOI:10.32364/2618-8430-2020-3-1-31-38
3. Gilliam ML, Derman RJ. Barrier methods of contraception. Obstet Gynecol Clin North Am. 2000;27(4):841-58. DOI:10.1016/s0889-8545(05)70174-1
4. DaVanzo J, Hale L, Razzaque A, Rahman M. Effects of interpregnancy interval and outcome of the preceding pregnancy on pregnancy outcomes in Matlab, Bangladesh. BJOG. 2007;114(9):1079-87. DOI:10.1111/j.1471-0528.2007.01338.x
5. Ross JA, Winfrey WL. Contraceptive use, intention to use and unmet needs during the extended postpartum period. Int Fam Plan Persctiv. 2001;27:20-7. DOI:10.2307/2673801
6. Ладодо О.Б, Жданова С.И., Зубков В.В., и др. Грудное вскармливание в России: проблемы и перспективы. Общественное здоровье. 2023;3(1):18-32 [Ladodo OB, Zhdanova SI, Zubkov VV, et al. Breastfeeding in Russia: Problems and prospects. Public Health. 2023;3(1):18-32 (in Russian)]. DOI:10.21045/2782-1676-2023-3-1-18-32
7. Labbok MH, Hight-Laukaran V, Peterson AE, et al. Multicenter study of the lactational amenorrhea method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception. 1997;55(6):327-36. DOI:10.1016/s0010-7824(97)00040-1
8. Hughes H. Postpartum contraception. J Fam Health Care. 2009;19(1):9-12. PMID:19370860
9. Caruso S, Rapisarda AMC, Minona P. Sexual activity and contraceptive use during social distancing and self-isolation in the COVID-19 pandemic. Eur J Contracept Reprod Health Care. 2020;25(6):445-8. DOI:10.1080/13625187.2020.1830965
10. Национальные медицинские критерии приемлемости методов контрацепции. М. 2023 [Natsional'nye meditsinskie kriterii priemlemosti metodov kontratseptsii. Moscow. 2023 (in Russian)].
11. Медицинские критерии приемлемости использования методов контрацепции ВОЗ. Пер. с англ. Европейского регионального бюро ВОЗ. 5-изд. Женева. 2015 [Meditsinskie kriterii priemlemosti ispol'zovaniia metodov kontratseptsii VOZ. Per. s angl. Evropeiskogo regional'nogo biuro VOZ. 5-izd. Geneva. 2015 (in Russian)].
12. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP); Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2018 update). Baltimore, Geneva: CCP and WHO, 2018.
13. Kunwar S, Faridi MM, Singh S, et al. Pattern and determinants of breast feeding and contraceptive practices among mothers within six months postpartum. Biosci Trends. 2010;4(4):186-9. PMID:20811138
14. Доброхотова Ю.Э., Мандрыкина Ж.А. Послеродовая контрацепция. Российский вестник акушера-гинеколога. 2012;12(4):99-103 [Dobrokhotova IuÉ, Mandrykina ZhA. Postpartum birth control. Russian Bulletin of Obstetrician-Gynecologist. 2012;12(4):99-103 (in Russian)].
15. Тихомиров А.Л., Олейник Ч.Г. Применение гормональных контрацептивов без эстрогенов в гинекологической практике. Гинекология. 2007;7(4):8-10 [Tikhomirov AL, Oleinik ChG. Primenenie gormonal'nykh kontratseptivov bez estrogenov v ginekologicheskoi praktike. Gynecology. 2007;7(4):8-10 (in Russian)].
16. Alfaiate MI, António Santos R, Silva AF, et al. Comparative in vitro study on the local tolerance and efficacy of benzalkonium chloride, myristalkonium chloride and nonoxynol-9 as active principles in vaginal contraceptives. Eur J Contracept Reprod Health Care. 2021;26(4):334-42. DOI:10.1080/13625187.2021.1900563
17. American College of Obstetrics and Gynecology. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstet Gynecol. 2016;128(2):e32-7. DOI:10.1097/AOG.0000000000001587
18. Lopez LM, Grey TW, Stuebe AM, et al. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev. 2015;2015(3):CD003988. DOI:10.1002/14651858.CD003988.pub2
19. Brito MB, Ferriani RA, Quintana SM, et al. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009;80(6):519-26. DOI:10.1016/j.contraception.2009.05.124
20. Прилепская В.Н. Руководство по контрацепции. М.: МЕДпресс-информ, 2017 [Prilepskaia VN. Rukovodstvo po kontratseptsii. Moscow: MEDpress-inform, 2017 (in Russian)].
21. Roth MY, Amory JK. Beyond the condom: Frontiers in male contraception. Semin Reprod Med. 2016;34(3):183-90. DOI:10.1055/s-0036-1571435
22. Forbes A, Heise L. What's up with nonoxynol-9. Reprod Health Matters. 2000;8(16):156-9. DOI:10.1016/s0968-8080(00)90199-x
23. Marmor D. Local spermicidal contraception. Gynecol Obstet Fertil. 2001;29(10):705-13. DOI:10.1016/s1297-9589(01)00213-2
24. Erny R, Porte H. Efficacy of spermicides. Contracept Fertil Sex (Paris). 1991;19(4):289-91. PMID:12343221
25. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404. DOI:10.1016/j.contraception.2011.01.021
26. Serfaty D. Contraception in breastfeeding women: Place for spermicides. J Gynecol Obstet Biol Reprod (Paris). 2015;44(1):18-27. DOI:10.1016/j.jgyn.2014.07.001
27. Serfaty D, Prilepskaya V, Graesslin O, et al. Efficacy, safety and acceptability of a benzalkonium chloride spermicide cream in women aged 40 years and over needing contraception: A prospective multicenter study. J Gynecol Obstet Hum Reprod. 2023;52(7):102616. DOI:10.1016/j.jogoh.2023.102616
28. Прилепская В.Н., Межевитинова Е.А., Назаренко Е.Г., Городнова Е.А. Ренессанс барьерной контрацепции (по результатам международного клинического исследования). Гинекология. 2021;23(5):380-5 [Prilepskaya VN, Mezhevitinova EA, Nazarenko EG, Gorodnova EA. The renaissance of barrier contraception (based on the data from an international clinical trial). Gynecology. 2021;23(5):380-5 (in Russian)]. DOI:10.26442/20795696.2021.5.201151
29. Grimes DA, Lopez LM, Raymond EG, et al. Spermicide used alone for contraception. Cochrane Database Syst Rev. 2013;(12):CD005218. DOI:10.1002/14651858.CD005218.pub4
30. Baptista M, Ramalho-Santos J. Spermicides, microbicides and antiviral agents: Recent advances in the development of novel multi-functional compounds. Mini Rev Med Chem. 2009;9(13):1556-67. DOI:10.2174/138955709790361548
31. Яглов В.В. Применение спермицидов – эффективный метод профилактики абортов и инфекций, передающихся половым путем. Фарматека. 2005;15:8-12 [Iaglov VV. Primenenie spermitsidov – effektivnyi metod profilaktiki abortov i infektsii, peredaiushchikhsia polovym putem. Farmateka. 2005;15:8-12 (in Russian)].
32. Серов В.Н. Местная (барьерная) контрацепция спермицидами в системе профилактики абортов. Вестник Российской ассоциации акушеров-гинекологов. 2001;2:62-5 [Serov VN. Mestnaia (bar'ernaia) kontratseptsiia spermitsidami v sisteme profilaktiki abortov. Vestnik Rossiiskoi Assotsiatsii Akusherov-Ginekologov. 2001;2:62-5 (in Russian)].
33. Леврие М. Применение влагалищных таблеток хлористого бензалкония в целях контрацепции. Гинекология. 1980;31(6):633-8 [Levrie M. Primenenie vlagalishchnykh tabletok khloristogo benzalkoniia v tseliakh kontratseptsii. Gynecology. 1980;31(6):633-8 (in Russian)].
34. Назарова Н.М., Прилепская В.Н., Некрасова М.Е. Послеродовая контрацепция: эффективность и безопасность. Гинекология. 2018;20(2):5-8 [Nazarova NM, Prilepskaya VN, Nekrasova ME. Postpartum contraception: Efficacy and safety. Gynecology. 2018;20(2):5-8 (in Russian)]. DOI:10.26442/2079-5696_2018.2.5-8
________________________________________________
1. Mikhailova OI, Veresova AA. Osobennosti poslerodovoi kontratseptsii v sovremennykh usloviiakh. Effektivnaia farmakoterapiia. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2013;2:26-30 (in Russian).
2. Bakhareva IV. Postpartum contraception: optimal choice. Russian Journal of Woman and Child Health. 2020;3(1):31-8 (in Russian). DOI:10.32364/2618-8430-2020-3-1-31-38
3. Gilliam ML, Derman RJ. Barrier methods of contraception. Obstet Gynecol Clin North Am. 2000;27(4):841-58. DOI:10.1016/s0889-8545(05)70174-1
4. DaVanzo J, Hale L, Razzaque A, Rahman M. Effects of interpregnancy interval and outcome of the preceding pregnancy on pregnancy outcomes in Matlab, Bangladesh. BJOG. 2007;114(9):1079-87. DOI:10.1111/j.1471-0528.2007.01338.x
5. Ross JA, Winfrey WL. Contraceptive use, intention to use and unmet needs during the extended postpartum period. Int Fam Plan Persctiv. 2001;27:20-7. DOI:10.2307/2673801
6. Ladodo OB, Zhdanova SI, Zubkov VV, et al. Breastfeeding in Russia: Problems and prospects. Public Health. 2023;3(1):18-32 (in Russian). DOI:10.21045/2782-1676-2023-3-1-18-32
7. Labbok MH, Hight-Laukaran V, Peterson AE, et al. Multicenter study of the lactational amenorrhea method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception. 1997;55(6):327-36. DOI:10.1016/s0010-7824(97)00040-1
8. Hughes H. Postpartum contraception. J Fam Health Care. 2009;19(1):9-12. PMID:19370860
9. Caruso S, Rapisarda AMC, Minona P. Sexual activity and contraceptive use during social distancing and self-isolation in the COVID-19 pandemic. Eur J Contracept Reprod Health Care. 2020;25(6):445-8. DOI:10.1080/13625187.2020.1830965
10. Natsional'nye meditsinskie kriterii priemlemosti metodov kontratseptsii. Moscow. 2023 (in Russian).
11. Meditsinskie kriterii priemlemosti ispol'zovaniia metodov kontratseptsii VOZ. Per. s angl. Evropeiskogo regional'nogo biuro VOZ. 5-izd. Geneva. 2015 (in Russian).
12. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP); Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2018 update). Baltimore, Geneva: CCP and WHO, 2018.
13. Kunwar S, Faridi MM, Singh S, et al. Pattern and determinants of breast feeding and contraceptive practices among mothers within six months postpartum. Biosci Trends. 2010;4(4):186-9. PMID:20811138
14. Dobrokhotova IuÉ, Mandrykina ZhA. Postpartum birth control. Russian Bulletin of Obstetrician-Gynecologist. 2012;12(4):99-103 (in Russian).
15. Tikhomirov AL, Oleinik ChG. Primenenie gormonal'nykh kontratseptivov bez estrogenov v ginekologicheskoi praktike. Gynecology. 2007;7(4):8-10 (in Russian).
16. Alfaiate MI, António Santos R, Silva AF, et al. Comparative in vitro study on the local tolerance and efficacy of benzalkonium chloride, myristalkonium chloride and nonoxynol-9 as active principles in vaginal contraceptives. Eur J Contracept Reprod Health Care. 2021;26(4):334-42. DOI:10.1080/13625187.2021.1900563
17. American College of Obstetrics and Gynecology. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstet Gynecol. 2016;128(2):e32-7. DOI:10.1097/AOG.0000000000001587
18. Lopez LM, Grey TW, Stuebe AM, et al. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev. 2015;2015(3):CD003988. DOI:10.1002/14651858.CD003988.pub2
19. Brito MB, Ferriani RA, Quintana SM, et al. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009;80(6):519-26. DOI:10.1016/j.contraception.2009.05.124
20. Prilepskaia VN. Rukovodstvo po kontratseptsii. Moscow: MEDpress-inform, 2017 (in Russian).
21. Roth MY, Amory JK. Beyond the condom: Frontiers in male contraception. Semin Reprod Med. 2016;34(3):183-90. DOI:10.1055/s-0036-1571435
22. Forbes A, Heise L. What's up with nonoxynol-9. Reprod Health Matters. 2000;8(16):156-9. DOI:10.1016/s0968-8080(00)90199-x
23. Marmor D. Local spermicidal contraception. Gynecol Obstet Fertil. 2001;29(10):705-13. DOI:10.1016/s1297-9589(01)00213-2
24. Erny R, Porte H. Efficacy of spermicides. Contracept Fertil Sex (Paris). 1991;19(4):289-91. PMID:12343221
25. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404. DOI:10.1016/j.contraception.2011.01.021
26. Serfaty D. Contraception in breastfeeding women: Place for spermicides. J Gynecol Obstet Biol Reprod (Paris). 2015;44(1):18-27. DOI:10.1016/j.jgyn.2014.07.001
27. Serfaty D, Prilepskaya V, Graesslin O, et al. Efficacy, safety and acceptability of a benzalkonium chloride spermicide cream in women aged 40 years and over needing contraception: A prospective multicenter study. J Gynecol Obstet Hum Reprod. 2023;52(7):102616. DOI:10.1016/j.jogoh.2023.102616
28. Prilepskaya VN, Mezhevitinova EA, Nazarenko EG, Gorodnova EA. The renaissance of barrier contraception (based on the data from an international clinical trial). Gynecology. 2021;23(5):380-5 (in Russian). DOI:10.26442/20795696.2021.5.201151
29. Grimes DA, Lopez LM, Raymond EG, et al. Spermicide used alone for contraception. Cochrane Database Syst Rev. 2013;(12):CD005218. DOI:10.1002/14651858.CD005218.pub4
30. Baptista M, Ramalho-Santos J. Spermicides, microbicides and antiviral agents: Recent advances in the development of novel multi-functional compounds. Mini Rev Med Chem. 2009;9(13):1556-67. DOI:10.2174/138955709790361548
31. Iaglov VV. Primenenie spermitsidov – effektivnyi metod profilaktiki abortov i infektsii, peredaiushchikhsia polovym putem. Farmateka. 2005;15:8-12 (in Russian).
32. Serov VN. Mestnaia (bar'ernaia) kontratseptsiia spermitsidami v sisteme profilaktiki abortov. Vestnik Rossiiskoi Assotsiatsii Akusherov-Ginekologov. 2001;2:62-5 (in Russian).
33. Levrie M. Primenenie vlagalishchnykh tabletok khloristogo benzalkoniia v tseliakh kontratseptsii. Gynecology. 1980;31(6):633-8 (in Russian).
34. Nazarova NM, Prilepskaya VN, Nekrasova ME. Postpartum contraception: Efficacy and safety. Gynecology. 2018;20(2):5-8 (in Russian). DOI:10.26442/2079-5696_2018.2.5-8
Авторы
В.Н. Прилепская*, Е.Г. Назаренко
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России, Москва, Россия
*v_prilepskaya@oparina4.ru
________________________________________________
Vera N. Prilepskaya*, Elena G. Nazarenko
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
*v_prilepskaya@oparina4.ru